As of the close on Friday, $S&P/ASX 200(XJO.AU)$ closed at 8,091.90 on Friday, up 0.85% in the past 5 days.
1. $IMUGENE LTD(IMU.AU)$ +19.23%
Imugene Limited is possibly approaching a major achievement in its business.Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia.
With the latest financial year loss of AU$38m and a trailing-twelve-month loss of AU$89m, the AU$375m market-cap company amplified its loss by moving further away from its breakeven target. A company's cash runway is calculated by dividing its cash hoard by its cash burn. In December 2023, Imugene had AU$139m in cash, and was debt-free. Looking at the last year, the company burnt through AU$73m.
Since it has a market capitalisation of AU$434m, Imugene's AU$73m in cash burn equates to about 17% of its market value. As a result, we'd venture that the company could raise more cash for growth without much trouble, albeit at the cost of some dilution. Even though its increasing cash burn makes us a little nervous, we are compelled to mention that we thought Imugene's cash runway was relatively promising.
2. $NANOSONICS LTD(NAN.AU)$ +19.19%
The share price of ASX 200 healthcare stock Nanosonics Ltd is 11.85% higher at $3.02 following the company's release of its full-year FY24 results. The Nanosonics share price opened at $2.86 and quickly ascended to an intraday high of $3.08 as investors digested news of a "significant turnaround" in the second half, with revenue rising 14%.
Magellan clocked a 31% increase in annual profit to A$238.8 million ($158.13 million) for the year ending June 2024, driven by higher performance fees and reduced expenses. Nanosonics said there was a significant turnaround in 2H FY24, which reversed the negative revenue growth in the first half. Revenue in the second half was 14% higher than the first half. This resulted in an increase in overall total revenue for the year by 2% to $170 million.
Nanosonics said research and development continued to be a cornerstone of future growth. The company invested $32.8 million in FY24, up 11% on FY23. The company said it progressed its Endoscope Reprocessing program with CORIS and new projects in its ultrasound reprocessing and connectivity product categories to advance its future product line.
3. $BEGA CHEESE LTD(BGA.AU)$ +16.44%
The Bega Cheese Ltd share price is rocketing this week because the company reported its latest earnings covering the full 20204 financial year.
Bega Cheese also reported a statutory profit after tax of $30.5 million, which was a pleasing turnaround from the statutory net loss of $229.5 million recorded over FY2023.
Bega's final dividend of 4 cents per share represents a 33.3% increase over the 3 cents per share final dividend from last year. Together with the April interim dividend of 4 cents per share, it takes Bega's full-year payouts to 8 cents per share, a 6.67% rise over FY2023's total of 7.5 cents
4. $DOWNER EDI LTD(DOW.AU)$ +15.73%
The Downer share price is up 15.73% to $5.59. This follows the release of a better than expected full year result from the integrated services provider. For FY 2024, Downer reported a 5.5% increase in revenue to $11,743.4 million and a 24.5% lift in underlying net profit after tax to $193.9 million.
“Downer continued to build momentum in its results delivering a 34% increase in pro forma EBITA of $384.1 million and EBITA margin growth of 0.7 percentage points to 3.3% for FY24,” the company reported.
Downer’s utilities business continued its turnaround to profitability with pro forma EBITA of $54.5 million (FY23: $10.7 million loss) “driven by a strong performance in telecommunications, the progressive completion of low margin contracts, settlement of contractual claims, the commercial reset of a loss-making power maintenance contract and the achievement of overhead cost reductions”.
5. $IDP EDUCATION LTD(IEL.AU)$ +10.52%
The IDP Education Ltd share price is charging higher on Thursday morning. At the time of writing, the language testing and student placement company's shares are up 10.52% to $16.18. This follows the release of the company's FY 2024 results before the market open.
For the 12 months ended 30 June, IDP Education delivered a 7% increase in revenue to a record of $1,037 million. This was driven predominantly by the company's Student Placement segment, which reported a 27% increase in revenue to $508.3 million. This offset an 11% decline in English Language Testing revenue in FY 2024.
Management advised that its record student placement revenue was driven by strong increases in both volume and price. It also highlights that it significantly outperformed the market, achieving 17% volume growth, while the broader industry saw a 13% volume decline due to tighter visa settings in key destination markets.
Comments
Cemennttt fuck